Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.
Tingen HSA, Tubben A, van 't Oever JH, Pastoor EM, van Zon PPA, Nienhuis HLA, van der Meer P, Slart RHJA. Tingen HSA, et al. Among authors: nienhuis hla. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):93-109. doi: 10.1007/s00259-023-06381-3. Epub 2023 Aug 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37561144 Free PMC article. Review.
Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC, Lemmink HH, Bijzet J, Glaudemans AWJM, Bos R, Plattel W, van den Berg MP, Slart RHJA, Nienhuis HLA, van Veldhuisen DJ, Hazenberg BPC. Klaassen SHC, et al. Among authors: nienhuis hla. Cardiovasc Pathol. 2017 Jul-Aug;29:19-22. doi: 10.1016/j.carpath.2017.04.002. Epub 2017 Apr 18. Cardiovasc Pathol. 2017. PMID: 28460244 Free article.
Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide.
Klaassen SHC, Tromp J, Nienhuis HLA, van der Meer P, van den Berg MP, Blokzijl H, van Veldhuisen DJ, Hazenberg BPC. Klaassen SHC, et al. Among authors: nienhuis hla. Am J Cardiol. 2018 Jan 1;121(1):107-112. doi: 10.1016/j.amjcard.2017.09.029. Epub 2017 Oct 14. Am J Cardiol. 2018. PMID: 29153245 Free article.
Time for new imaging and therapeutic approaches in cardiac amyloidosis.
Slart RHJA, Glaudemans AWJM, Noordzij W, Bijzet J, Hazenberg BPC, Nienhuis HLA. Slart RHJA, et al. Among authors: nienhuis hla. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1402-1406. doi: 10.1007/s00259-019-04325-4. Epub 2019 Apr 23. Eur J Nucl Med Mol Imaging. 2019. PMID: 31016330 No abstract available.
99mTc-aprotinin imaging in cardiac amyloidosis. Make an old tool new again?
Slart RHJA, Glaudemans AWJM, Noordzij W, Nienhuis HLA, Hazenberg BPC. Slart RHJA, et al. Among authors: nienhuis hla. J Nucl Cardiol. 2020 Aug;27(4):1155-1157. doi: 10.1007/s12350-019-01917-3. Epub 2019 Oct 10. J Nucl Cardiol. 2020. PMID: 31602569 No abstract available.
Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis.
Groothof D, Nienhuis HLA, Bijzet J, Houwerzijl EJ, van den Berg MP, Glaudemans AWJM, Slart RHJA, Hazenberg BPC. Groothof D, et al. Among authors: nienhuis hla. Mayo Clin Proc. 2020 Feb;95(2):417-418. doi: 10.1016/j.mayocp.2019.10.036. Epub 2019 Dec 26. Mayo Clin Proc. 2020. PMID: 31883697 No abstract available.
Correction to: Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.
Tingen HSA, Tubben A, van 't Oever JH, Pastoor EM, van Zon PPA, Nienhuis HLA, van der Meer P, Slart RHJA. Tingen HSA, et al. Among authors: nienhuis hla. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1798. doi: 10.1007/s00259-023-06408-9. Eur J Nucl Med Mol Imaging. 2024. PMID: 37606860 Free PMC article. No abstract available.
35 results